System: [6,12,13,19,20-Pentakis[6-[4-(5-nonyl-1,3,4-thiadiazol-2-yl)phenoxy]hexanoyloxy]-5-tetracyclo[15.4.0.03,8.010,15]henicosa-1(21),3,5,7,10,12,14,17,19-nonaenyl] 6-[4-(5-nonyl-1,3,4-thiadiazol-2-yl)phenoxy]hexanoate
Use the dropdown to view details on the components
| 1) [6,12,13,19,20-Pentakis[6-[4-(5-nonyl-1,3,4-thiadiazol-2-yl)phenoxy]hexanoyloxy]-5-tetracyclo[15.4.0.03,8.010,15]henicosa-1(21),3,5,7,10,12,14,17,19-nonaenyl] 6-[4-(5-nonyl-1,3,4-thiadiazol-2-yl)phenoxy]hexanoate | |
|---|---|
| DECHEMA ID | 110143 |
| Formula | C159H210N12O18S6 |
| Synonym | 2,3,7,8,12,13-Hexakis{6-[4-(5-nonyl-1,3,4-thiadiazol-2-yl)phenoxy]hexanoyloxy}-10,15-dihydro-5H-tribenzo[a,d,g]cyclononene |
| InChi-Key | VFDGDVNLJRQFMG-UHFFFAOYSA-N |
| Registry No. | D903582532 |
Available physical property data:
| Property | Phase | No. of tables | No. of lines | Data |
|---|---|---|---|---|
| temperature of phase transition | - | 2 | 2 | View |